Optimizing neuroblastoma treatment with 131I-mIBG targeted therapy

Therapeutic optimization of the radioactive drug 131I-mIBG to improve treatment of neuroblastoma. Neuroblastoma, a rare childhood cancer, accounts for 8 to 10 % of pediatric cancers. Although this cancer is particularly aggressive, advances in imaging techniques, notably thanks to radioactive tracers such as 123I-mIBG, mean that it can now be detected more effectively. However, [...]